All stock lists
Xpeng Inc. (NYSE:XPEV)
China · Delayed Price · Currency is USD
Consumer Cyclical · Auto Manufacturers
9.12-0.09 (-0.98%)
Insider Score
––Not scored
XPEV Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
XPEV analyst forecast
XPEV analyst consensus
Hold2 ratings
Buy 0 Hold 1 Sell 1
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
XPEV 12-month price target
$21.53+136.1% upsideaverage of 6 firms
$34.00High
$12.00Low
Best analysts covering XPEV
- JP Morgan50%success rate · 4 calls
- Barclays33%success rate · 6 calls
- Macquarie0%success rate · 3 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
XPEV analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-10-26 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-09-29 |
| UBS | — | $12.00 | +9.8% | — | 2026-09-09 | |
| Barclays | Underweight | $14.00 | +25.6% | Reiterated | 2026-08-26 | |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-08-25 |
| — | Barclays | Underweight | — | — | Reiterated | 2026-07-16 |
| Macquarie | Outperform | $19.00 | +15.6% | Upgraded | 2026-05-29 | |
| Jefferies | — | $25.20 | +53.3% | — | 2026-05-29 | |
| — | Barclays | Underweight | — | — | Reiterated | 2026-03-24 |
| — | Macquarie | Neutral | — | — | Downgraded | 2026-03-23 |
| Macquarie | — | $26.00 | +24.4% | — | 2026-01-15 | |
| — | Freedom Broker | Buy | — | — | Upgraded | 2026-01-06 |
| — | Freedom Capital Markets | Buy | — | — | Upgraded | 2026-01-06 |
| Loop Capital Markets | — | $25.00 | +24.1% | — | 2026-01-06 | |
| Morgan Stanley | — | $34.00 | +30.6% | — | 2025-11-11 | |
| — | Citigroup | Buy | — | — | Reiterated | 2025-08-20 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-08-19 |
| — | Macquarie | Outperform | — | — | Reiterated | 2025-08-15 |
| Goldman Sachs | — | $24.00 | +29.2% | — | 2025-06-17 | |
| Morgan Stanley | — | $28.00 | +45.6% | — | 2025-06-12 | |
| Macquarie | Outperform | $24.00 | +7.9% | Upgraded | 2025-05-22 | |
| Bernstein | — | $19.00 | -7.3% | — | 2025-05-22 | |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-05-21 |
| — | Barclays | Underweight | — | — | Reiterated | 2025-03-20 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-03-19 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-03-19 |
| — | Citigroup | Buy | — | — | Upgraded | 2025-03-10 |
| — | UBS | Neutral | — | — | Upgraded | 2025-02-24 |
| — | Macquarie | Neutral | — | — | Downgraded | 2025-02-07 |
| — | UBS | Sell | — | — | Downgraded | 2024-12-05 |
| — | China Renaissance | Buy | — | — | Upgraded | 2024-11-22 |
| — | Bernstein | Market Perform | — | — | Reiterated | 2024-11-20 |
| — | Citigroup | Neutral | — | — | Reiterated | 2024-11-20 |
| CMB International Securities | — | $16.00 | +26.6% | — | 2024-11-20 | |
| Morgan Stanley | — | $17.00 | +31.9% | — | 2024-11-06 | |
| Citigroup | — | $14.60 | +14.8% | — | 2024-09-30 | |
| Citigroup | — | $10.30 | -3.7% | — | 2024-09-24 | |
| — | JP Morgan | Overweight | — | — | Upgraded | 2024-09-05 |
| Macquarie | — | $10.00 | +18.9% | — | 2024-09-03 | |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-08-21 |
| Citigroup | Neutral | $7.60 | +12.3% | Reiterated | 2024-08-21 | |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-08-21 |
| Barclays | — | $7.00 | +3.4% | — | 2024-08-21 | |
| — | B of A Securities | Buy | — | — | Reiterated | 2024-07-16 |
| — | Citigroup | Neutral | — | — | Upgraded | 2024-06-25 |
| Daiwa | — | $11.00 | +35.8% | — | 2024-05-23 | |
| Bernstein | — | $12.00 | +36.8% | — | 2024-05-22 | |
| Barclays | — | $8.00 | -8.8% | — | 2024-05-22 | |
| CFRA | — | $8.00 | +3.1% | — | 2024-04-01 | |
| HSBC | — | $18.70 | +119.5% | — | 2024-03-22 | |
| Morgan Stanley | — | $18.00 | +82.0% | — | 2024-03-19 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-03-11 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2024-02-23 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2023-09-22 |
| — | Barclays | Underweight | — | — | Reiterated | 2023-08-22 |
| — | B of A Securities | Buy | — | — | Upgraded | 2023-08-21 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2023-08-21 |
XPEV earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-20 | 0.00 | 0.06 | $3.07B | $3.18B |
| 2026-05-28 | -0.11 | -0.27 | $1.87B | $1.89B |
| 2026-08-24 | -0.06 | -0.21 | $3.02B | $2.91B |
| 2026-11-16 | -0.11 | 0.00 | $3.48B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.